Not a member? Sign up for free!

FDA Issues Recommendations To Encourage Development Of Opioid Use Disorder Treatment Medications

News | September 17, 2018

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

On August 6, 2018, the U.S. Food and Drug Administration (FDA) issued new scientific recommendations to drug sponsors to encourage medication assisted treatment (MAT) drug development for the treatment of opioid use disorder (OUD). The recommendations promote both creation and improvement of these drugs by suggesting new methods of measuring and demonstrating the effectiveness and…

You must be logged in to read the full article: Join PsychU or Log In